Medigus Ltd. WT C EXP 072...

NASDAQ: MDGSW · Real-Time Price · USD
0.02
-0.00 (-13.42%)
At close: Jul 19, 2023, 8:44 PM

Medigus WT C EXP 072323 Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
91.86M 10.12M
Cost of Revenue
77.41M 5.32M
Gross Profit
14.45M 4.8M
Operating Income
-13.78M -8.2M
Interest Income
n/a n/a
Pretax Income
-10.1M 4.15M
Net Income
-10.21M 4.05M
Selling & General & Admin
18.18M 11.95M
Research & Development
4.85M 1.04M
Other Expenses
45K 494K
Operating Expenses
23.03M 13M
Interest Expense
n/a n/a
Selling & Marketing Expenses
4.01M 1.99M
Cost & Expenses
100.44M 18.31M
Income Tax Expense
111K 105K
Shares Outstanding (Basic)
n/a 460.72M
Shares Outstanding (Diluted)
n/a 460.72M
EPS (Basic)
n/a 0.01
EPS (Diluted)
n/a 0.01
EBITDA
-11.99M -22.23M
EBIT
-14.18M n/a
Depreciation & Amortization
1.8M -14.03M